On November 9, the State Food and Drug Administration approved the listing of biological hernia repair patches in accordance with the "Special Review Procedures for Innovative Medical Devices." This is the 130th innovative medical device approved for marketing since the establishment of the “special review channel for innovative medical devices” in 2014.

　　Innovative medical devices are medical devices that have my country's invention patents, are technologically pioneered in China, and are internationally advanced, and have significant clinical application value. The State Food and Drug Administration will give priority to review and approval on the premise that the standards and procedures are not reduced.

　　These innovative medical devices are launched on the market, stimulate innovation vitality, release reform dividends, meet the needs of the people, and effectively protect the lives and health of the people!